FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
IPO Status: Listed [27th Jul 2021 to 29th Jul 2021]
We have captured total 15 recommendations for Glenmark Life Sciences IPO. Out of 15 , 13 financial institutes/analysts have given rating for Subscribe, 0 for May Apply (50-50), 0 for Avoid and 0 hasn't given any rating. In terms of percentage 86.67% institutes has rated Glenmark Life Sciences IPO for subscribe.
Here we have covered Glenmark Life Sciences IPO Notes from Research Analysts and provided you their recommendations. These research notes will give you 360 degree view of Glenmark Life Sciences IPO. Some research analysts give clear recommendations and some left decision on you with complete analysis. We try to add the information as on when we receive the document.
Zerodha Trade@20
Glenmark Life Sciences IPO details includes issue size, issue price, discount information, minimum and maximum order quantity, promoters holding details, NSE and BSE code.
IPO Details | Values |
---|---|
IPO IPO Open Date | 27th Jul 2021 |
IPO IPO Close Date | 29th Jul 2021 |
IPO Issue Size | ₹1513.60 Cr |
IPO Issue Price | ₹695-720 |
Market Lot | 20 Shares |
Latest and updated information about Glenmark Life Sciences IPO. Dates are updated as they are announced.
IPO Activity | Date |
---|---|
IPO IPO Open Date | 27th Jul 2021 |
IPO IPO Close Date | 29th Jul 2021 |
Basis of Allotment Finalisation Date* | 3rd Aug 2021 |
Refunds Initiation* | 4th Aug 2021 |
Credit of Shares to Demat Account* | 5th Aug 2021 |
IPO Listing Date* | 6th Aug 2021 |
* - Tentative Dates
Last Updated on 2021-09-27T10:41:33+00:00